NRI

PROCTER & GAMBLE HEALTH SHARE PRICE

Sector Pharmaceuticals
BSE 500126
NSE PGHL
5,169.50
1.00 (0.02 %)
Buy
B
Sell
S
NSE BSE

Overview

Day Low

5,150.00

Day High

5,205.50

52 Week Low

4,636.55

52 Week High

5,850.00

All Time Low

243.30

All Time High

7,500.00

Open

5,165.50

Close

5,168.50

Volume

2,331

Mkt cap (Cr)

8,580.85

P/E ratio

34.93

P/B ratio

0.07%

Div yield

5.03%

6M return

1.07%

1Y return

9.96%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

5,169.50 0.02%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Procter & Gamble Health Ltd

Stock PE (TTM)

34.93

Promoter Holding

51.82%

Book Value

367.7603

ROCE

39.76%

ROE

31.18%

Proctor & Gamble Health Ltd is in the Pharmaceuticals sector is having a market capitalization worth Rs. 8,936.24 crores, it was incorporated in the year 1967. It has reported consolidated sales of Rs. 22,239.0 crores in March’2021. The company is listed on the Bombay Stock Exchange (BSE) with the code 500126 and is listed on the National Stock Exchange (NSE) with the code PGHL.

Proctor & Gamble Health Ltd, originally incorporated under the name Merck Ltd, is involved in manufacturing and supplying pharmaceuticals and chemicals. The company's pharmaceuticals division is involved in producing prescription drugs, biotechnology products, and consumer health products. At the same time, the chemicals division is involved in supplying pharmaceutical chemicals, formulated chemical products, industrial chemicals, and other chemical products. Proctor & Gamble completed the acquisition of Merck Ltd in December’2018. Its manufacturing facility is established in Goa. Proctor & Gamble Health Ltd, in pursuing the Corporate Social Responsibility requirements, have introduced various health and education schemes aimed at underprivileged children and women of the country. The promoters of the company own 51.82% of the stake in the company, Foreign Institutional Investors (FII) own 6.45%, Domestic Institutional Investors (DII) own 11.81% stake in the company, and others (such as public & retail investors) hold the balance of 29.92%.

In March 2021, quarterly net revenue was Rs. 219.15 crores, which has decreased marginally by approximately 3.93 % from Rs. 228.11 crores for the January-March 2020 quarter. The quarterly net profit in March 2021 was Rs. 15.17 crores, which has reduced and decreased by nearly 67.35% from a net profit of Rs. 46.46 crores in March 2020. In March 2021, the reported operating profit was at Rs. 138.29 crores, which is also decreased by 19.76% as compared to an operating profit of Rs. 172.34 crores for the quarter ending in March 2020. From an EPS of Rs. 28 in March 2020, the EPS of Proctor & Gamble Health Ltd has reduced and reached Rs. 9.5 per share in March 2021. PGHL's stock closed at Rs. 5,383.60 on 20th August’2021 (NSE) and has given a negative return of 23.78% in the last six months and an annual return of 14.67% in the previous year.

Procter & Gamble Health share price as on 23 Apr 2025 is Rs. 5169.5. Over the past 6 months, the Procter & Gamble Health share price has increased by 1.07% and in the last one year, it has increased by 9.96%. The 52-week low for Procter & Gamble Health share price was Rs. 4636.55 and 52-week high was Rs. 5850.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

500126

PGHL

INE199A01012

Dec

Procter & Gamble Health Ltd FAQs

You can buy Procter & Gamble Health Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Procter & Gamble Health Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 23, 2025 10:49 AM the closing price of Procter & Gamble Health Ltd was Rs.5,169.50.

The latest PE ratio of Procter & Gamble Health Ltd as of Apr 23, 2025 10:49 AM is 34.93

The latest PB ratio of Procter & Gamble Health Ltd as of Apr 23, 2025 10:49 AM is 0.07

The 52-week high of Procter & Gamble Health Ltd share price is Rs. 5,850.00 while the 52-week low is Rs. 4,636.55

According to analyst recommendations, Procter & Gamble Health Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Apr 23, 2025 10:49 AM, the market cap of Procter & Gamble Health Ltd stood at Rs. 8,580.85 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.